Biotech companies are seeing sharp pre-market activity this Tuesday, hinting at possible breakout opportunities.
By evaluating sentiment and momentum before the bell, premarket analysis becomes a foundational step in any trader's pre market routine.
In the Green - Premarket Gainers
On Tuesday, the following stocks are trading significantly higher in the premarket session.
1. Autolus Therapeutics PLC. (AUTL) - up 27% at $1.582. Cassava Sciences Inc. (SAVA) - up 11% at $3.213. Fulcrum Therapeutics Inc. (FULC) - up 8% at $12.654. Quantum Biopharma Ltd. (QNTM) - up 8% at $6.205. Select Medical Holdings Corp. (SEM) - up 7% at $15.006. Vir Biotechnology Inc. (VIR) - up 6% at $6.517. ProPhase Labs Inc. (PRPH) - up 5% at $0.198. BioAffinity Technologies Inc. (BIAF) - up 4% at $1.499. PTC Therapeutics, Inc. (PTCT) - up 3% at $82.6310. Longeveron Inc. (DNTH) - up 1% at $0.63
For comments and feedback contact: editorial@rttnews.com
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.